Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Soluble CD39: ex vivo dose-response evaluation in combination with known antiplatelet agents

Nov. 14, 2000

Venous and arterial antithrombotic effects described at AHA meeting for DPC-423

Nov. 14, 2000

Melagatran dose-dependently reduces platelet and fibrin deposition following angioplasty

Nov. 14, 2000

DuPont prepares aryl sulfonyl-based factor Xa inhibitors

Nov. 13, 2000

Novel series of anticoagulants patented by Kissei research team

Nov. 13, 2000

First potent and selective, nonpeptide thrombin receptor antagonists described by Schering-Plough

Nov. 9, 2000

Selective factor Xa inhibitors designed by Cor Therapeutics researchers

Nov. 8, 2000

New protein from leeches with utility in thromboembolic diseases

Oct. 27, 2000

C&C describes new series of thrombin inhibitors

Oct. 25, 2000

U.S. launch of Innohep as DVT therapy announced at San Francisco meeting

Oct. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...